Concepedia

Carolin Ertl

CE

Statistics

Publications

3

Citations

74

H-Index

3

Active since

2023

Affiliations

Düsseldorf University Hospital(Current)

Universitätsklinikum Erlangen

Johannes Wesling Klinikum Minden

Friedrich-Alexander-Universität Erlangen-Nürnberg

University of Miami

Carolin Ertl is an author at Düsseldorf University Hospital specializing in oncology, immune checkpoint resistance, and cancer immunology.

ORCID

Publications per year

2023–2024

3

Publications

3

Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitors

Theresa Ruf, Rafaela Kramer, Andrea Forschner et al. · European Journal of Cancer · 2024 · 47 citations · Full text

, , +17

The side effect registry immuno-oncology (SERIO) – A tool for systematic analysis of immunotherapy-induced side effects

Carolin Ertl, Theresa Ruf, Dirk Mentzer et al. · European Journal of Cancer · 2023 · 16 citations

, , +16

Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity

Ying Wang, Carolin Ertl, Christina Schmitt et al. · Frontiers in Cardiovascular Medicine · 2024 · 11 citations · Full text

, , +17

1–3 of 3